MedTrace Logo

Clinical Evaluation of Genetron Lung Cancer Panel in Non-small Cell Lung Cancer Patients

NCT05023746 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1052

Last updated 2021-09-01

No results posted yet for this study

Summary

The purpose of this trail is to evaluate the performance of Genetron lung cancer panel in non-small cell lung cancer patients using semiconductor sequencing method.

Conditions

Interventions

DIAGNOSTIC_TEST

Genetron lung cancer panel

Follows the principle of synchronous blinding. The enrolled cases are coded, and the enrolled samples are detected with Genetron lung cancer panel and comparison methods. The detection results are compared, and the samples that are inconsistent with the detection results of similar products on the market are reviewed by the the Sanger sequencing method, when the site detection results compared with Sanger sequencing method are inconsistent, Sanger's detection results are recognized. The results were determined independently according to the cutoff values or interpretation requirements provided by each method, and relevant statistics were used to evaluate clinical application performance of Genetron lung cancer panel.

Sponsors & Collaborators

  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences

    collaborator OTHER

  • The Second Affiliated Hospital Zhejiang University School of Medcine

    collaborator UNKNOWN

  • Henan Cancer Hospital

    collaborator OTHER_GOV

  • The First Hospital of Jilin University

    collaborator OTHER

  • Genetron Health (Beijing) Co., Ltd.

    collaborator UNKNOWN

  • Genetron Health

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-30
Primary Completion
2019-09-09
Completion
2019-09-17

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05023746 on ClinicalTrials.gov